ArticleWorld journal of urology2015

Urothelial carcinogen resistance driven by stronger Toll-like receptor 2 (TLR2) and Uroplakin III (UP III) defense mechanisms: a new model.

Leonardo Oliveira Reis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.